Acute Myocardial Infarction clinical trials

Explore recruiting acute myocardial infarction clinical trials.

Recruiting acute myocardial infarction studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Myocardial Infarction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) Metformin in Patients with Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT) A randomized, 2 x 2 factorial designed, double-blind, placebo controlled study (DANHEART).

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction

Austria, Netherlands, Denmark, Poland, Romania, Slovakia +17 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin trial

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Randomised study for double-blind, placebo-controlled evaluation of BI 765845 on top of standard of care in patients with myocardial infarction

Slovakia, Poland, Germany, Czechia, Hungary, Italy +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)

Spain, Netherlands, Italy

Therapeutic use (Phase IV) EU CTIS Study details

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Acute Myocardial Infarction trials by city

Acute Myocardial Infarction clinical trials

Recruiting acute myocardial infarction studies right now

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes

Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction

Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain

Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)

Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion

Very Early PCSK9 Inhibition for Acute Myocardial Infarction

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury

Also recruiting in Europe

Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin trial

Randomised study for double-blind, placebo-controlled evaluation of BI 765845 on top of standard of care in patients with myocardial infarction

Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy (TARGET-FIRST)

MAMI Use of the Methoxyflurane as pain-killer in the prehospital management of Acute Myocardial Infarction

Acute Myocardial Infarction trials by city

Other conditions